Tofacitinib 10 MG [Xeljanz] ( DrugBank: Tofacitinib )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
97潰瘍性大腸炎1

97. 潰瘍性大腸炎


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04925973
(ClinicalTrials.gov)
June 1, 20218/6/2021Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis ManagementTofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (the TRIUMPH Study)Ulcerative Colitis AcuteDrug: Tofacitinib 10 MG [Xeljanz]McMaster UniversityUniversity of Manitoba;University of British Columbia;McGill University;University of AlbertaRecruiting18 YearsN/AAll26Phase 2Canada